 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LIGAND PHARMACEUTICALS INC (LGND)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-06-04 Sale | 2020-06-05 4:07 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 11,146 | $118.59 | $1,321,775 | 40,877 (Direct) | View |
| 2020-08-21 Sale | 2020-08-25 7:10 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,303 | $112.86 | $824,190 | 155,413 (Direct) | View |
| 2020-08-25 Sale | 2020-08-27 7:06 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) | View |
| 2020-08-25 Sale(A) | 2020-08-28 5:11 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) | View |
| 2020-11-02 Purchase | 2020-11-04 4:19 pm | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 1,000 | $82.52 | $82,520 | 28,190 (Direct) | View |
| 2021-01-25 Sale | 2021-01-27 7:04 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 90,000 | $169.22 | $15,230,000 | 243,422 (Direct) | View |
| 2021-02-03 Sale | 2021-02-05 5:03 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 44,547 | $176.86 | $7,878,582 | 168,198 (Direct) | View |
| 2021-02-03 Sale | 2021-02-05 5:03 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 18,097 | $178.5 | $3,230,376 | 28,906 (Direct) | View |
| 2021-02-05 Sale | 2021-02-09 6:08 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 54,666 | $203.4 | $11,119,239 | 286,030 (Direct) | View |
| 2021-02-09 Sale | 2021-02-11 4:06 pm | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 14,670 | $208.53 | $3,059,123 | 24,431 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 6:23 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 5,083 | $213.14 | $1,083,410 | 47,678 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,918 | $120.86 | 136,981 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,689 | $120.86 | 135,292 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,310 | $120.86 | 133,982 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 938 | $120.86 | 124,615 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,246 | $120.86 | 123,369 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 642 | $120.86 | 122,727 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 354 | $120.86 | 16,115 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 377 | $120.86 | 15,738 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 435 | $120.86 | 15,303 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 831 | $0 | 27,190 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 831 | $0 | 24,768 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:33 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 831 | $0 | 27,208 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:33 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 831 | $0 | 3,072 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 831 | $0 | 50,305 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 831 | $0 | 2,262 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 831 | $0 | 68,034 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:46 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 831 | $0 | 24,431 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:46 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,468 | $0 | 2,468 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 238 | $89.03 | 25,936 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 238 | $89.03 | 41,115 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,165 | $85.79 | 201,421 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,777 | $56.26 | 203,198 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,373 | $74.42 | 204,571 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2025-02-10 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,777 | $0 | 54,421 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2024-02-12 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,373 | $0 | 93,627 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,165 | $0 | 54,226 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 790 | $74.42 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 162,638 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 78 | $21.92 | 155,491 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $0 | 0 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 78 | $0 | 64,547 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2024-02-12 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 790 | $0 | 64,210 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-10 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 20,000 | $10.05 | 224,571 (Direct) | View |
| 2020-11-09 Tax Withholding | 2020-11-10 7:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,458 | $81.77 | 222,113 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-10 7:41 pm | N/A 2021-02-17 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 20,000 | $0 | 74,657 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-09 6:12 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 14,657 | $10.05 | 236,770 (Direct) | View |
| 2020-12-08 Tax Withholding | 2020-12-09 6:12 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,683 | $87.52 | 235,087 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-09 6:12 pm | N/A 2021-02-17 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 14,657 | $0 | 60,000 (Direct) | View |
| 2020-12-31 Other | 2021-01-05 8:30 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 223 | $84.53 | 235,310 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,456 | $113.5 | 52,761 (Direct) | View |
| 2021-01-27 Exercise | 2021-01-27 7:02 pm | N/A 2027-05-25 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,456 | $0 | 0 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 1,335 | $0 | 42,450 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 509 | $156.1 | 41,941 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 2,401 | $0 | 44,342 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 830 | $156.01 | 43,512 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 2,305 | $0 | 28,241 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 671 | $156.01 | 27,570 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 4,803 | $0 | 32,373 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 1,440 | $156.01 | 30,933 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,911 | $0 | 158,324 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,053 | $156.01 | 157,271 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 5,604 | $0 | 162,875 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,272 | $156.01 | 160,603 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 50,000 | $14.47 | 285,310 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 5,946 | $0 | 241,256 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,845 | $156.01 | 238,411 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 9,607 | $0 | 248,018 (Direct) | View |
| 2021-01-25 Tax Withholding | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 4,596 | $156.01 | 243,422 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 40,000 | $14.47 | 283,422 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 30,000 | $21.92 | 273,422 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 50,000 | $0 | 109,000 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 40,000 | $0 | 69,000 (Direct) | View |
| 2021-01-25 Exercise | 2021-01-27 7:04 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 30,000 | $0 | 65,616 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 10,819 | $0 | 41,752 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A 2031-02-03 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 11,591 | $0 | 11,591 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 12,608 | $0 | 286,030 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:02 pm | N/A 2031-02-03 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 25,113 | $0 | 25,113 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 6,595 | $0 | 167,198 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-05 5:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,000 | $74.42 | 168,198 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-05 5:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 44,547 | $21.92 | 212,745 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-05 5:03 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 44,547 | $0 | 20,000 (Direct) | View |
| 2021-02-03 Exercise | 2021-02-05 5:03 pm | N/A 2024-02-12 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,000 | $0 | 63,210 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:03 pm | N/A 2031-02-03 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 13,136 | $0 | 13,136 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:03 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 3,491 | $0 | 47,003 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:03 pm | N/A 2021-02-03 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 6,955 | $0 | 6,955 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 6:08 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 54,666 | $14.47 | 340,696 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 6:08 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 60,000 | $10.05 | 346,030 (Direct) | View |
| 2021-02-05 Tax Withholding | 2021-02-09 6:08 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,970 | $203.03 | 343,060 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 6:08 pm | N/A 2021-02-17 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 60,000 | $0 | 0 (Direct) | View |
| 2021-02-05 Exercise | 2021-02-09 6:08 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 54,666 | $0 | 14,334 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 7,335 | $10.12 | 31,766 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 7,335 | $12.53 | 39,101 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:06 pm | N/A 2021-06-01 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 7,335 | $0 | 0 (Direct) | View |
| 2021-02-09 Exercise | 2021-02-11 4:06 pm | N/A 2022-05-31 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 7,335 | $0 | 0 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $195.91 | 50,152 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:23 pm | N/A 2028-06-18 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $0 | 0 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 434 | $172.46 | 41,318 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 906 | $172.46 | 40,412 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 969 | $172.46 | 39,443 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,204 | $172.46 | 341,856 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,947 | $172.46 | 339,909 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,061 | $172.46 | 337,848 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 641 | $172.46 | 167,557 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,235 | $172.46 | 166,322 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,222 | $172.46 | 165,100 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 205 | $172.46 | 28,701 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 368 | $172.46 | 28,333 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 442 | $172.46 | 27,891 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 5:18 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $10.12 | 29,708 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 5:18 pm | N/A 2012-06-01 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $0 | 4,835 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:57 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,835 | $10.12 | 34,543 (Direct) | View |
| 2021-05-11 Tax Withholding | 2021-05-13 8:57 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 391 | $128.56 | 34,152 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:57 pm | N/A 2012-06-01 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,835 | $0 | 0 (Direct) | View |